MedTrace Logo

A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant

NCT02367261 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2017-06-28

No results posted yet for this study

Summary

The current prospective clinical study's aim is to determine ABT's SPI implant survival rate, crestal interproximal bone resorption during 24 months post implant insertion and to assimilate the drilling sequence during the clinical use of SPI implants.

Conditions

  • Implant Clinical Survival
  • Dental Implant Bone Loss

Interventions

DEVICE

SPI implant

SPI implant - the original spiral implant

Sponsors & Collaborators

  • Alpha - Bio Tec Ltd.

    lead INDUSTRY

Principal Investigators

  • Yi Man, Dr · West China Hospital of Stomatology, Chengdu, Sichuan China

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02367261 on ClinicalTrials.gov